Urging Support for the Alzheimer’s Screening and Prevention (ASAP) Act
July 14, 2026 - Health Subcommittees of the House Ways & Means, House Energy & Commerce, and Senate Finance Committees
AWHP sent letters to the health subcommittees of the House Ways & Means, House Energy & Commerce, and Senate Finance Committees.
Gratitude for Introduction of the Alzheimer’s Screening and Prevention (ASAP) Act
July 14, 2026 - Representative Tonko, Representative Buchanan, and Senator Collins
AWHP sent letters of support to the original co-sponsors of the Alzheimer’s Screening and Prevention (ASAP) Act.
Urging Reconsideration of the Proposed Removal of MassHealth Coverage for Obesity Management Medications
June 25, 2026 - Massachusetts Budget Conference Committee
AWHP urged members of the Massachusetts legislature to reconsider the proposed removal of MassHealth coverage for obesity management medications when prescribed solely for weight loss.
Urging Reconsideration of the Proposed Removal of Rhode Island Medicaid Coverage for Obesity Management Medications When Prescribed Solely for Weight Loss
June 4, 2026 - Senate President Lawson, Senate Finance Chair DiPalma and House Speaker Blazejewski
AWHP expressed its disappointment with the recently proposed removal of Rhode Island Medicaid coverage for obesity management medications when prescribed solely for weight loss in the FY2027 budget.
Testimony in Support of Louisiana SB 433
May 18, 2026 - Louisiana House Committee on Health and Welfare
AWHP sent a letter to the Louisiana House Committee on Health and Welfare to expand access to comprehensive obesity treatment by requiring the state’s Medicaid managed care organizations to cover obesity management medications.
Urging Removal of the Prohibition on Medicaid Coverage for Obesity Medications in §5160-9-03 of the Ohio Administrative Code
May 5, 2026 - Ohio Governor Mike DeWine
AWHP sent a letter to Ohio Governor Mike DeWine urging him to remove the prohibition on Medicaid coverage for obesity medications in the Ohio Administrative Code.
Testimony in Support of NH SB455
April 14, 2026 - New Hampshire House Commerce and Consumer Affairs Committee
AWHP provided testimony in support of SB455, which would improve access to FDA-approved obesity management medications for Medicaid beneficiaries.
Urging Reconsideration of the Proposed Removal of Rhode Island Medicaid Coverage for Obesity Management Medications When Prescribed Solely for Weight Loss
April 8, 2026 - Rhode Island Governor Dan McKee
AWHP expressed its disappointment with the recently proposed removal of Rhode Island Medicaid coverage for obesity management medications when prescribed solely for weight loss.
Urging Reconsideration of the Proposed Removal of Rhode Island Medicaid Coverage for Obesity Management Medications When Prescribed Solely for Weight Loss
April 8, 2026 - Rhode Island Senate Finance Committee
AWHP expressed its disappointment with the recently proposed removal of Rhode Island Medicaid coverage for obesity management medications when prescribed solely for weight loss.